The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma

By Eriksen Jesper Grau   Steiniche Torben   Overgaard Jens  

Acta Oncologica, Vol. 44, Iss. 1, 2005-02 ,pp. : 50-58

Informa Healthcare

Access to resources Recommend Favorite

Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features

By Rodrigo J.P.   Domnguez F.   Alvarez C.   Manrique C.   Herrero A.   Suarez C.  

European Journal of Cancer, Vol. 38, Iss. 8, 2002-05 ,pp. : 1059-1064

Elsevier

Access to resources Recommend Favorite

Comparison of Induction Chemotherapy Before Radiotherapy with Radiotherapy Only in Patients with Locally Advanced Squamous Cell Carcinoma of the Lung

By Brodin O.   Nou E.   Mercke C.   Linden C.J.   Lundstrom R.   Arwidi A.   Brink J.   Ringborg U.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 1893-1900

Elsevier

Access to resources Recommend Favorite

Clinical significance of KRAS gene mutation and epidermal growth factor receptor expression in Japanese patients with squamous cell carcinoma of the larynx, oropharynx and hypopharynx

By Fujii Satoshi  

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 454-463

Springer Publishing Company

Access to resources Recommend Favorite

Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: A Danish nationwide survey from DAHANCA

By Primdahl Hanne   Linnet Nielsen Anni   Larsen Susanne   Andersen Elo   Ipsen Merete   Lajer Christel   Weber Vestermark Lene   Andersen Lisbeth   Sand Hansen Hanne   Overgaard Marie   Overgaard Jens   Grau Cai  

Acta Oncologica, Vol. 45, Iss. 2, 2006-03 ,pp. : 156-161

Informa Healthcare

Access to resources Recommend Favorite